1. Home
  2. OMIC vs ELEV Comparison

OMIC vs ELEV Comparison

Compare OMIC & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMIC
  • ELEV
  • Stock Information
  • Founded
  • OMIC 2016
  • ELEV 2019
  • Country
  • OMIC United States
  • ELEV United States
  • Employees
  • OMIC 127
  • ELEV N/A
  • Industry
  • OMIC Medical/Dental Instruments
  • ELEV Biotechnology: Pharmaceutical Preparations
  • Sector
  • OMIC Health Care
  • ELEV Health Care
  • Exchange
  • OMIC Nasdaq
  • ELEV Nasdaq
  • Market Cap
  • OMIC 49.8M
  • ELEV 37.6M
  • IPO Year
  • OMIC 2021
  • ELEV 2021
  • Fundamental
  • Price
  • OMIC $19.66
  • ELEV $0.66
  • Analyst Decision
  • OMIC Hold
  • ELEV Buy
  • Analyst Count
  • OMIC 2
  • ELEV 6
  • Target Price
  • OMIC $10.75
  • ELEV $7.20
  • AVG Volume (30 Days)
  • OMIC 24.5K
  • ELEV 1.1M
  • Earning Date
  • OMIC 11-12-2024
  • ELEV 11-06-2024
  • Dividend Yield
  • OMIC N/A
  • ELEV N/A
  • EPS Growth
  • OMIC N/A
  • ELEV N/A
  • EPS
  • OMIC N/A
  • ELEV N/A
  • Revenue
  • OMIC $2,667,000.00
  • ELEV N/A
  • Revenue This Year
  • OMIC $3.98
  • ELEV N/A
  • Revenue Next Year
  • OMIC $242.05
  • ELEV N/A
  • P/E Ratio
  • OMIC N/A
  • ELEV N/A
  • Revenue Growth
  • OMIC 2.77
  • ELEV N/A
  • 52 Week Low
  • OMIC $5.34
  • ELEV $0.50
  • 52 Week High
  • OMIC $23.41
  • ELEV $5.83
  • Technical
  • Relative Strength Index (RSI)
  • OMIC 47.98
  • ELEV 57.62
  • Support Level
  • OMIC $19.25
  • ELEV $0.56
  • Resistance Level
  • OMIC $20.00
  • ELEV $0.61
  • Average True Range (ATR)
  • OMIC 0.65
  • ELEV 0.05
  • MACD
  • OMIC -0.07
  • ELEV -0.00
  • Stochastic Oscillator
  • OMIC 22.76
  • ELEV 76.65

About OMIC Singular Genomics Systems Inc.

Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Share on Social Networks: